Assessing somatization in urologic chronic pelvic pain syndrome.

Szczegóły
Abstrakt

Tytuł:: Assessing somatization in urologic chronic pelvic pain syndrome.
Autorzy:: North CS; The Altshuler Center for Education & Research at Metrocare Services, The University of Texas Southwestern Medical Center, 1250 Mockingbird Lane, Suite 330, Dallas, TX, 75247-4914, USA. .; Department of Psychiatry, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Suite NE5.102, Dallas, TX, 75390-9070, USA. .
Hong BA; Department of Psychiatry, School of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Lai HH; Departments of Surgery and Anesthesiology, Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Alpers DH; Department of Internal Medicine, Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Źródło:: BMC urology [BMC Urol] 2019 Dec 10; Vol. 19 (1), pp. 130. Date of Electronic Publication: 2019 Dec 10.
Typ publikacji:: Comparative Study; Journal Article
Język:: English
Imprint Name(s):: Original Publication: London : BioMed Central, [2001-
MeSH Terms:: Chronic Pain/*psychology
Pelvic Pain/*psychology
Somatoform Disorders/*diagnosis
Cystitis, Interstitial/psychology ; Female ; Health Surveys ; Humans ; Male ; Middle Aged ; Prevalence ; Prostatitis/psychology ; Self Report ; Sensitivity and Specificity ; Somatoform Disorders/epidemiology ; Symptom Assessment/methods ; Syndrome
References:: J Urol. 2001 Aug;166(2):557-61; discussion 561-2. (PMID: 11458068)
Arch Gen Psychiatry. 1972 Jan;26(1):57-63. (PMID: 5009428)
BMC Fam Pract. 2014 Jun 05;15:109. (PMID: 24903850)
J Urol. 2012 Jun;187(6):2106-12. (PMID: 22503014)
J Psychiatr Res. 1997 Jan-Feb;31(1):125-31. (PMID: 9201654)
Urology. 1997 May;49(5A Suppl):58-63. (PMID: 9146003)
Aust N Z J Psychiatry. 2013 May;47(5):483-4. (PMID: 23653063)
BMC Psychiatry. 2013 Mar 20;13:91. (PMID: 23514436)
Ann Fam Med. 2009 May-Jun;7(3):232-8. (PMID: 19433840)
J Psychosom Res. 2013 Dec;75(6):584. (PMID: 24290051)
J Psychosom Res. 2013 Dec;75(6):586-7. (PMID: 24290053)
Epidemiol Psychiatr Sci. 2015 Jun;24(3):188-96. (PMID: 25675983)
Psychosom Med. 2002 Mar-Apr;64(2):258-66. (PMID: 11914441)
J Urol. 2017 Sep;198(3):622-631. (PMID: 28373134)
Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59. (PMID: 20633738)
Br J Psychiatry. 1968 Sep;114(514):1115-9. (PMID: 5684660)
BMC Urol. 2014 Aug 01;14:58. (PMID: 25085119)
J Urol. 2014 Jun;191(6):1802-7. (PMID: 24361369)
Annu Rev Clin Psychol. 2016;12:105-32. (PMID: 26772207)
Rheum Dis Clin North Am. 2009 May;35(2):339-57. (PMID: 19647147)
N Engl J Med. 1962 Mar 1;266:421-6. (PMID: 14485393)
Urology. 2009 Nov;74(5):983-7, quiz 987.e1-3. (PMID: 19800663)
JAMA. 1982 May 14;247(18):2559-64. (PMID: 7069922)
Soc Psychiatry Psychiatr Epidemiol. 2006 Sep;41(9):704-12. (PMID: 16794766)
Dtsch Arztebl Int. 2015 Apr 17;112(16):279-87. (PMID: 25939319)
Grant Information:: U01 DK082325 United States DK NIDDK NIH HHS; U01 DK82315 United States NH NIH HHS
Contributed Indexing:: Keywords: Chronic prostatitis; Interstitial cystitis; Polysymptomatic; Polysyndromic; Psychiatric diagnosis; Psychoform; Somatization disorder; Somatoform; Symptom screening; Urological chronic pelvic pain syndrome
Entry Date(s):: Date Created: 20191212 Date Completed: 20200518 Latest Revision: 20200518
Update Code:: 20240105
PubMed Central ID:: PMC6902613
DOI:: 10.1186/s12894-019-0556-3
PMID:: 31823813
: Czasopismo naukowe

Full Text Finder

Background: This study examined the prevalence of somatization disorder in Urological Chronic Pelvic Pain Syndrome (UCPPS) and the utility of two self-report symptom screening tools for assessment of somatization in patients with UCPPS.
Methods: The study sample included 65 patients with UCPPS who enrolled in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Study at Washington University. Patients completed the PolySymptomatic PolySyndromic Questionnaire (PSPS-Q) (n = 64) and the Patient Health Questionnaire-15 Somatic Symptom Severity Scale (PHQ-15) (n = 50). Review of patient medical records found that only 47% (n = 30) contained sufficient documentation to assess Perley-Guze criteria for somatization disorder.
Results: Few (only 6.5%) of the UCPPS sample met Perley-Guze criteria for definite somatization disorder. Perley-Guze somatization disorder was predicted by definite PSPS-Q somatization with at least 75% sensitivity and specificity. Perley-Guze somatization disorder was predicted by severe (> 15) PHQ-15 threshold that had > 90% sensitivity and specificity but was met by only 16% of patients. The moderate (> 10) PHQ-15 threshold had higher sensitivity (100%) but lower specificity (52%) and was met by 52% of the sample.
Conclusions: The PHQ-15 is brief, but it measures symptoms constituting only one dimension of somatization. The PSPS-Q uniquely captures two conceptual dimensions inherent in the definition of somatization disorder, both number of symptoms and symptom distribution across multiple organ systems, with relevance for UCPPS as a syndrome that is not just a collection of urological symptoms but a broader syndrome with symptoms extending beyond the urological system.

Informacja